Lung CCellsBasic, translational, and clinical research within the Hillman Lung Cancer Program (LCP) aims to define the molecular pathways that contribute to lung cancer development and progression, to translate these findings into novel therapies for improved clinical outcomes, and to improve prevention, early detection and risk prediction for lung cancer.

Read more about the Lung Cancer Program

See Program Members

Research Themes:

Early Detection, Risk Prediction, and Prevention

Identify high-risk individuals and improve prevention and early detection of lung cancer

New Therapeutic Targets and Rational Combinations of Targeted Therapies

Define molecular pathways that promote lung cancer and develop novel therapies for improved clinical outcomes